SALE
市場調查報告書

印度的體外受精 (IVF)市場:至2025年的預測與市場機會

India In-vitro Fertilization Market By Technique, By Equipment, By Fertilization, By Donor, By Infertility, By Embryo, By Application, By End User, By Region, Competition, Forecast & Opportunities, 2025

出版商 TechSci Research 商品編碼 938731
出版日期 內容資訊 英文 71 Pages
商品交期: 請詢問到貨日
價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

印度的體外受精 (IVF)市場:至2025年的預測與市場機會 India In-vitro Fertilization Market By Technique, By Equipment, By Fertilization, By Donor, By Infertility, By Embryo, By Application, By End User, By Region, Competition, Forecast & Opportunities, 2025
出版日期: 2020年05月01日內容資訊: 英文 71 Pages
簡介

印度的體外受精市場在預測期間預計將以穩定的速度成長。市場,預期由國家醫療基礎設施的改善與以合理價格可利用最新的醫療設施所帶動。

本報告提供印度的體外受精市場各市場區隔和各地區調查,市場規模及市場佔有率的預測,推動因素與課題,市場趨勢,競爭情形,企業簡介等資訊。

目錄

第1章 產品概要

第2章 調查手法

第3章 摘要整理

第4章 客戶的迴響

第5章 印度的體外受精市場預測

  • 市場規模與預測
  • 市場佔有率與預測
    • 各技術(時序指導(IC)或週期監測,排卵誘發(OI),人工授精(IUI),捐贈者受精(IUDI),卵子提供(DOP),體外受精,顯微授精,胚玻璃化、凍結胚移植(FET),精巢精子開採(TESE)、經皮精巢上身精子吸引(PESA))
    • 各設備(IVF培養基,IVF培養箱,微機械手,低溫系統櫃,吸引幫浦,其他)
    • 各受精(標準授精,卵細胞質內單一精蟲顯微注射術(ICSI),子宮內受精)
    • 各捐贈者(自體,同類,代理)
    • 各不孕症(男性,女性,男性、女性的雙方)
    • 各胚(新鮮胚,凍結融化胚)
    • 各用途(輸卵管的損傷或閉塞,排卵障礙,子宮內膜異位症,子宮肌瘤,輸卵管的殺菌或消除,精子的生成或功能的障礙,原因不明的不孕症,遺傳性障礙,癌症或其他的健康狀態的不孕治療)
    • 各終端用戶(不孕治療診所,醫院,其他)
    • 各地區
    • 各企業
  • 市場魅力指數

第6章 北印度的體外受精市場展望

  • 市場規模與預測
  • 市場佔有率與預測
    • 各技術
    • 各設備
    • 各受精
    • 各捐贈者
    • 各不孕
    • 各胚
    • 各用途
    • 各終端用戶

第7章 南印度的體外受精市場展望

  • 市場規模與預測
  • 市場佔有率與預測
    • 各技術
    • 各設備
    • 各受精
    • 各捐贈者
    • 各不孕
    • 各胚
    • 各用途
    • 各終端用戶

第8章 東印度的體外受精市場展望

  • 市場規模與預測
  • 市場佔有率與預測
    • 各技術
    • 各設備
    • 各受精
    • 各捐贈者
    • 各不孕
    • 各胚
    • 各用途
    • 各終端用戶

第9章 西印度的體外受精市場展望

  • 市場規模與預測
  • 市場佔有率與預測
    • 各技術
    • 各設備
    • 各受精
    • 各捐贈者
    • 各不孕
    • 各胚
    • 各用途
    • 各終端用戶

第10章 市場動態

  • 成長要素/機會
  • 課題要素/限制

第11章 市場趨勢與趨勢

第12章 政策和法規情形

第13章 印度的經濟簡介

CHAPTER14: 競爭情形

  • 企業簡介
    • Lab IVF
    • Lg Life sciences India Pvt. Ltd
    • Merck
    • Cook Medical
    • Cipla
    • Alembic Pharmaceutical
    • Glenmark pharmaceutical
    • Cadila pharmaceutical
    • Cooper Surgical
    • Fujifilm
    • Hamilton Thorne
    • Nikon cooperation
    • Thermo Fisher Scientific Inc.
    • Vitrolife AB
    • Adorefem
    • Sobha Medical Equipment
    • ART Biotech
    • SAR Healthline
    • Surelife

第15章 策略性推薦事項

第16章 我免責聲明

目錄
Product Code: 4533

India in-vitro fertilization market is expected to grow at a formidable rate during the forecast period. The India in-vitro fertilization market is driven by the improving healthcare infrastructure in the country and availability of modern healthcare facilities at affordable prices. This fact is also giving rise to medical tourism thereby propelling the market in the country. Additionally, changing lifestyle patterns are leading to various diseases such as PCOS and other kinds of reproductive diseases. Furthermore, increasing number of single super specialty hospitals is projected to fuel the market over the next few years.

The India in-vitro fertilization market is segmented based on technique, equipment, fertilization, donor, infertility, embryo, application, end user, region and company. Based on equipment, the market can be fragmented into IVF culture media, IVF incubators, micromanipulator, cryosystem cabinet, aspiration pumps and others. The IVF culture media segment is expected to dominate the market during the forecast period since culture media is required in every IVF procedure. Semen processing media, ovum processing media, cryopreservation media, and embryo culture media are the major culture media types used during IVF procedures. Additionally, major players are launching improved versions of their culture media thereby driving the growth of segment.

Major players operating in the India in-vitro fertilization market include Lab IVF, Lg Life sciences India Pvt. Ltd, Merck, Cook Medical, Cipla, Alembic Pharmaceutical, Glenmark pharmaceutical, Cadila pharmaceutical, Cooper Surgical, Fujifilm, Hamilton Thorne, Nikon cooperation, Thermo Fisher Scientific Inc., Vitrolife AB, Adorefem, Sobha Medical Equipment, ART Biotech, SAR Healthline, Surelife and others.

Years considered for this report:

Historical Years: 2015-2018

Base Year: 2019

Estimated Year: 2020

Forecast Period: 2021-2025

Objective of the Study:

  • To analyze and forecast the market size of India in-vitro fertilization market.
  • To classify and forecast India in-vitro fertilization market based on technique, equipment, fertilization, donor, infertility, embryo, application, end user, company and regional distribution.
  • To identify drivers and challenges for India in-vitro fertilization market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in India in-vitro fertilization market.
  • To conduct pricing analysis for India in-vitro fertilization market.
  • To identify and analyze the profile of leading players operating in India in-vitro fertilization market.

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of fertility centers across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the manufacturers which could not be identified due to the limitations of secondary research. TechSci Research analyzed the manufacturers, distribution channels and presence of all major players across the globe.

TechSci Research calculated the market size of India in-vitro fertilization market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience:

  • In-vitro fertilization fertility centers, hospitals/clinics and other stakeholders
  • Government bodies such as regulating authorities and policy makers
  • Organizations, forums and alliances related to in-vitro fertilization
  • Market research and consulting firms

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as fertility centers, hospitals and clinics, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope:

In this report, India in-vitro fertilization market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • Market, By Technique:

Timed Intercourse (IC) or Cycle Monitoring

Ovulation Induction (OI)

Artificial insemination using Partner's semen (IUI)

Donor Insemination (IUDI)

Oocyte Donation (DOP)

In-vitro Fertilization

Intra cytoplasmic sperm injection

Embryo Vitrification & Frozen Embryo Transfer (FET)

Testicular Sperm Extraction (TESE) & Percutaneous Epididymal Sperm Aspiration (PESA)

  • Market, By Equipment:

IVF culture media

IVF incubators

Micromanipulator

Cryosystem cabinet

Aspiration pumps

Others

  • Market, By Fertilization:

Conventional Insemination

Intracytoplasmic sperm injection (ICSI)

Intra-uterine Fertilization

  • Market, By Donor:

Autologous

Allogenic

Surrogacy

  • Market, By Infertility:

Male

Female

Both male and female

  • Market, By Embryo:

Fresh embryo

Frozen-thawed embryo

  • Market, By Application:

Fallopian tube damage or blockage

Ovulation disorders

Endometriosis

Uterine fibroids

Previous tubal sterilization or removal

Impaired sperm production or function

Unexplained infertility

Genetic disorder

Fertility preservation for cancer

Other health conditions

  • Market, By End User:

Fertility clinics

Hospitals

Others

  • Market, By Region:

North

South

East

West

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in India in-vitro fertilization market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product of Interest Introduction: In-vitro Fertilization

2. Research Methodology

3. Executive Summary

4. Voice of Customer

5. India In-vitro Fertilization Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Technique (Timed Intercourse (IC) or Cycle Monitoring, Ovulation Induction(OI) , Artificial insemination using Partner's semen(IUI) ,Donor Insemination (IUDI), Oocyte Donation (DOP),In-vitro Fertilization, Intra cytoplasmic sperm injection, Embryo Vitrification & Frozen Embryo Transfer (FET), Testicular Sperm Extraction (TESE) & Percutaneous Epididymal Sperm Aspiration (PESA))
    • 5.2.2. By Equipment (IVF culture media, IVF incubators, Micromanipulator, Cryosystem cabinet, Aspiration pumps and others)
    • 5.2.3. By Fertilization (Conventional Insemination, Intracytoplasmic sperm injection (ICSI), Intra-uterine Fertilization)
    • 5.2.4. By Donor (Autologous, Allogenic, Surrogacy)
    • 5.2.5. By Infertility (Male, Female, Both male and female)
    • 5.2.6. By Embryo (Fresh embryo and Frozen-thawed embryo)
    • 5.2.7. By Application (Fallopian tube damage or blockage, Ovulation disorders, Endometriosis, Uterine fibroids, Previous tubal sterilization or removal, Impaired sperm production or function, Unexplained infertility, Genetic disorder, Fertility preservation for cancer or other health conditions)
    • 5.2.8. By End User (Fertility clinics, Hospitals and others)
    • 5.2.9. By Region (North, South, East, West)
    • 5.2.10. By Company
  • 5.3. Market Attractiveness Index

6. North India In-vitro Fertilization Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Technique
    • 6.2.2. By Equipment
    • 6.2.3. By Fertilization
    • 6.2.4. By Donor
    • 6.2.5. By Infertility
    • 6.2.6. By Embryo
    • 6.2.7. By Application
    • 6.2.8. By End User

7. South India In-vitro Fertilization Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Technique
    • 7.2.2. By Equipment
    • 7.2.3. By Fertilization
    • 7.2.4. By Donor
    • 7.2.5. By Infertility
    • 7.2.6. By Embryo
    • 7.2.7. By Application
    • 7.2.8. By End User

8. East India In-vitro Fertilization Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Technique
    • 8.2.2. By Equipment
    • 8.2.3. By Fertilization
    • 8.2.4. By Donor
    • 8.2.5. By Infertility
    • 8.2.6. By Embryo
    • 8.2.7. By Application
    • 8.2.8. By End User

9. West India In-vitro Fertilization Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Technique
    • 9.2.2. By Equipment
    • 9.2.3. By Fertilization
    • 9.2.4. By Donor
    • 9.2.5. By Infertility
    • 9.2.6. By Embryo
    • 9.2.7. By Application
    • 9.2.8. By End User

10. Market Dynamics

  • 10.1. Drivers/Opportunities
  • 10.2. Challenges/Restraints

11. Market Trends & Developments

12. Policy & Regulatory Landscape

13. India Economic Profile

14. Competitive Landscape

  • 14.1. Company Profiles
    • 14.1.1. Lab IVF
    • 14.1.2. Lg Life sciences India Pvt. Ltd
    • 14.1.3. Merck
    • 14.1.4. Cook Medical
    • 14.1.5. Cipla
    • 14.1.6. Alembic Pharmaceutical
    • 14.1.7. Glenmark pharmaceutical
    • 14.1.8. Cadila pharmaceutical
    • 14.1.9. Cooper Surgical
    • 14.1.10. Fujifilm
    • 14.1.11. Hamilton Thorne
    • 14.1.12. Nikon cooperation
    • 14.1.13. Thermo Fisher Scientific Inc.
    • 14.1.14. Vitrolife AB
    • 14.1.15. Adorefem
    • 14.1.16. Sobha Medical Equipment
    • 14.1.17. ART Biotech
    • 14.1.18. SAR Healthline
    • 14.1.19. Surelife

15. Strategic Recommendations

16. About Us & Disclaimer